Cargando…
(652) Effect of Seroconversion after SARS-CoV-2 Vaccination on the Severity of COVID-19 Disease in Heart Transplant Recipients
PURPOSE: Heart transplant (HTX) recipients are prone to develop serious symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their vaccination is often ineffective. In this high-volume single center study, we aimed to examine the seroconversion rates achieved wit...
Autores principales: | Kugler, S., Vári, D., Veres, D., Király, Á., Teszák, T., Parázs, N., Tarjányi, Z., Drobni, Z., Szakál-Tóth, Z., Prinz, G., Miheller, P., Merkely, B., Sax, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068088/ http://dx.doi.org/10.1016/j.healun.2023.02.666 |
Ejemplares similares
-
Seroconversion after SARS‐CoV‐2 vaccination is protective against severe COVID‐19 disease in heart transplant recipients
por: Kugler, Szilvia, et al.
Publicado: (2023) -
Pseudoaneurysm of the ascending aorta: case report of a donor-derived Pseudomonas infection in a heart transplant recipient
por: Kugler, Szilvia, et al.
Publicado: (2021) -
CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
por: Déri, Máté, et al.
Publicado: (2021) -
Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients
por: Agbim, Uchenna, et al.
Publicado: (2020) -
Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus‐positive patient with fulminant myocarditis
por: Szakal‐Toth, Zsofia, et al.
Publicado: (2021)